nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A4—Temozolomide—brain cancer	0.14	0.387	CbGbCtD
Fluticasone Propionate—CYP3A4—Lomustine—brain cancer	0.119	0.329	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—brain cancer	0.0739	0.204	CbGbCtD
Fluticasone Propionate—CYP3A4—Etoposide—brain cancer	0.0288	0.0795	CbGbCtD
Fluticasone Propionate—Menopause—Procarbazine—brain cancer	0.0209	0.0541	CcSEcCtD
Fluticasone Propionate—Hyperadrenocorticism—Temozolomide—brain cancer	0.0185	0.048	CcSEcCtD
Fluticasone Propionate—Cushing's syndrome—Carmustine—brain cancer	0.013	0.0338	CcSEcCtD
Fluticasone Propionate—Skin atrophy—Hydroxyurea—brain cancer	0.0121	0.0315	CcSEcCtD
Fluticasone Propionate—Hoarseness—Procarbazine—brain cancer	0.0108	0.0279	CcSEcCtD
Fluticasone Propionate—Throat sore—Lomustine—brain cancer	0.0103	0.0268	CcSEcCtD
Fluticasone Propionate—Oropharyngeal discomfort—Lomustine—brain cancer	0.0103	0.0266	CcSEcCtD
Fluticasone Propionate—Fluocinonide—SMO—brain cancer	0.01	0.906	CrCbGaD
Fluticasone Propionate—Contusion—Lomustine—brain cancer	0.00855	0.0222	CcSEcCtD
Fluticasone Propionate—Oropharyngeal pain—Lomustine—brain cancer	0.0082	0.0213	CcSEcCtD
Fluticasone Propionate—SERPINA6—hindbrain—brain cancer	0.00795	0.0646	CbGeAlD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00776	0.0658	CbGpPWpGaD
Fluticasone Propionate—NR3C2—hindbrain—brain cancer	0.00649	0.0528	CbGeAlD
Fluticasone Propionate—PGR—blood vessel—brain cancer	0.00632	0.0514	CbGeAlD
Fluticasone Propionate—PGR—hindbrain—brain cancer	0.00603	0.0491	CbGeAlD
Fluticasone Propionate—Dysphonia—Procarbazine—brain cancer	0.00575	0.0149	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00538	0.0456	CbGpPWpGaD
Fluticasone Propionate—Blister—Hydroxyurea—brain cancer	0.00508	0.0132	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Carmustine—brain cancer	0.00466	0.0121	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Temozolomide—brain cancer	0.00451	0.0117	CcSEcCtD
Fluticasone Propionate—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00429	0.0365	CbGpPWpGaD
Fluticasone Propionate—Influenza-like symptoms—Temozolomide—brain cancer	0.00401	0.0104	CcSEcCtD
Fluticasone Propionate—NR3C2—brainstem—brain cancer	0.00372	0.0302	CbGeAlD
Fluticasone Propionate—NR3C1—hindbrain—brain cancer	0.00348	0.0283	CbGeAlD
Fluticasone Propionate—Endocrine disorder—Temozolomide—brain cancer	0.00345	0.00895	CcSEcCtD
Fluticasone Propionate—PLA2G4A—pituitary gland—brain cancer	0.0033	0.0269	CbGeAlD
Fluticasone Propionate—NR3C2—telencephalon—brain cancer	0.0033	0.0268	CbGeAlD
Fluticasone Propionate—SERPINA6—pituitary gland—brain cancer	0.00329	0.0268	CbGeAlD
Fluticasone Propionate—PGR—Nuclear signaling by ERBB4—GFAP—brain cancer	0.00323	0.0274	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—OTX2—brain cancer	0.0032	0.0272	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—endocrine gland—brain cancer	0.0032	0.026	CbGeAlD
Fluticasone Propionate—PLA2G4A—medulla oblongata—brain cancer	0.00319	0.0259	CbGeAlD
Fluticasone Propionate—Viral infection—Temozolomide—brain cancer	0.00317	0.00821	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Temozolomide—brain cancer	0.00311	0.00805	CcSEcCtD
Fluticasone Propionate—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.0031	0.0264	CbGpPWpGaD
Fluticasone Propionate—Infection—Carboplatin—brain cancer	0.00302	0.00783	CcSEcCtD
Fluticasone Propionate—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00299	0.0253	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00296	0.0251	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—midbrain—brain cancer	0.00291	0.0237	CbGeAlD
Fluticasone Propionate—PLA2G4A—spinal cord—brain cancer	0.00284	0.0231	CbGeAlD
Fluticasone Propionate—Candida infection—Carmustine—brain cancer	0.00283	0.00733	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Hydroxyurea—brain cancer	0.00278	0.00721	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Temozolomide—brain cancer	0.00278	0.00721	CcSEcCtD
Fluticasone Propionate—Candida infection—Temozolomide—brain cancer	0.00273	0.00708	CcSEcCtD
Fluticasone Propionate—NR3C2—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00271	0.023	CbGpPWpGaD
Fluticasone Propionate—NR3C2—pituitary gland—brain cancer	0.00269	0.0219	CbGeAlD
Fluticasone Propionate—Pneumonia—Procarbazine—brain cancer	0.00266	0.00691	CcSEcCtD
Fluticasone Propionate—Infection—Lomustine—brain cancer	0.00264	0.00685	CcSEcCtD
Fluticasone Propionate—Pain—Carboplatin—brain cancer	0.0026	0.00674	CcSEcCtD
Fluticasone Propionate—NR3C2—medulla oblongata—brain cancer	0.00259	0.0211	CbGeAlD
Fluticasone Propionate—Face oedema—Hydroxyurea—brain cancer	0.00257	0.00666	CcSEcCtD
Fluticasone Propionate—PLA2G4A—endocrine gland—brain cancer	0.00256	0.0208	CbGeAlD
Fluticasone Propionate—SERPINA6—endocrine gland—brain cancer	0.00255	0.0207	CbGeAlD
Fluticasone Propionate—SERPINA6—head—brain cancer	0.00252	0.0205	CbGeAlD
Fluticasone Propionate—Epistaxis—Procarbazine—brain cancer	0.0025	0.00648	CcSEcCtD
Fluticasone Propionate—PGR—pituitary gland—brain cancer	0.0025	0.0203	CbGeAlD
Fluticasone Propionate—Diabetes mellitus—Carmustine—brain cancer	0.00247	0.00641	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Carboplatin—brain cancer	0.0024	0.00623	CcSEcCtD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—ESR2—brain cancer	0.0024	0.0203	CbGpPWpGaD
Fluticasone Propionate—NR3C2—midbrain—brain cancer	0.00237	0.0193	CbGeAlD
Fluticasone Propionate—NR3C2—spinal cord—brain cancer	0.00231	0.0188	CbGeAlD
Fluticasone Propionate—PLA2G4A—central nervous system—brain cancer	0.00231	0.0188	CbGeAlD
Fluticasone Propionate—SERPINA6—central nervous system—brain cancer	0.0023	0.0187	CbGeAlD
Fluticasone Propionate—Nasal congestion—Temozolomide—brain cancer	0.00228	0.00591	CcSEcCtD
Fluticasone Propionate—SERPINA6—cerebellum—brain cancer	0.00225	0.0183	CbGeAlD
Fluticasone Propionate—Candida infection—Etoposide—brain cancer	0.00219	0.00567	CcSEcCtD
Fluticasone Propionate—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00213	0.0181	CbGpPWpGaD
Fluticasone Propionate—Arrhythmia—Procarbazine—brain cancer	0.00212	0.00551	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Lomustine—brain cancer	0.0021	0.00545	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptors—ESR2—brain cancer	0.00209	0.0177	CbGpPWpGaD
Fluticasone Propionate—NR3C2—endocrine gland—brain cancer	0.00208	0.0169	CbGeAlD
Fluticasone Propionate—Face oedema—Carmustine—brain cancer	0.00208	0.00538	CcSEcCtD
Fluticasone Propionate—NR3C2—head—brain cancer	0.00205	0.0167	CbGeAlD
Fluticasone Propionate—Infestation NOS—Hydroxyurea—brain cancer	0.00205	0.00531	CcSEcCtD
Fluticasone Propionate—Infestation—Hydroxyurea—brain cancer	0.00205	0.00531	CcSEcCtD
Fluticasone Propionate—Face oedema—Temozolomide—brain cancer	0.00201	0.0052	CcSEcCtD
Fluticasone Propionate—NR3C1—brainstem—brain cancer	0.00199	0.0162	CbGeAlD
Fluticasone Propionate—Tremor—Procarbazine—brain cancer	0.00194	0.00503	CcSEcCtD
Fluticasone Propionate—PGR—endocrine gland—brain cancer	0.00193	0.0157	CbGeAlD
Fluticasone Propionate—PGR—head—brain cancer	0.00191	0.0155	CbGeAlD
Fluticasone Propionate—NR3C2—central nervous system—brain cancer	0.00188	0.0153	CbGeAlD
Fluticasone Propionate—NR3C2—cerebellum—brain cancer	0.00183	0.0149	CbGeAlD
Fluticasone Propionate—PLA2G4A—brain—brain cancer	0.00183	0.0149	CbGeAlD
Fluticasone Propionate—SERPINA6—brain—brain cancer	0.00182	0.0148	CbGeAlD
Fluticasone Propionate—Abdominal distension—Temozolomide—brain cancer	0.00181	0.00469	CcSEcCtD
Fluticasone Propionate—Cough—Procarbazine—brain cancer	0.00181	0.00468	CcSEcCtD
Fluticasone Propionate—Hypertension—Procarbazine—brain cancer	0.00179	0.00463	CcSEcCtD
Fluticasone Propionate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00178	0.0151	CbGpPWpGaD
Fluticasone Propionate—NR3C1—telencephalon—brain cancer	0.00177	0.0144	CbGeAlD
Fluticasone Propionate—Arthralgia—Procarbazine—brain cancer	0.00176	0.00457	CcSEcCtD
Fluticasone Propionate—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00176	0.0149	CbGpPWpGaD
Fluticasone Propionate—Anxiety—Procarbazine—brain cancer	0.00176	0.00455	CcSEcCtD
Fluticasone Propionate—PGR—central nervous system—brain cancer	0.00174	0.0142	CbGeAlD
Fluticasone Propionate—Bronchitis—Temozolomide—brain cancer	0.00173	0.00448	CcSEcCtD
Fluticasone Propionate—Dry mouth—Procarbazine—brain cancer	0.00172	0.00447	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Etoposide—brain cancer	0.00172	0.00445	CcSEcCtD
Fluticasone Propionate—PGR—cerebellum—brain cancer	0.0017	0.0139	CbGeAlD
Fluticasone Propionate—Vomiting—Lomustine—brain cancer	0.00169	0.00439	CcSEcCtD
Fluticasone Propionate—Oedema—Procarbazine—brain cancer	0.00169	0.00438	CcSEcCtD
Fluticasone Propionate—Infection—Procarbazine—brain cancer	0.00168	0.00435	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Carmustine—brain cancer	0.00168	0.00435	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Temozolomide—brain cancer	0.00167	0.00433	CcSEcCtD
Fluticasone Propionate—Pneumonia—Carmustine—brain cancer	0.00167	0.00432	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00165	0.014	CbGpPWpGaD
Fluticasone Propionate—Tachycardia—Procarbazine—brain cancer	0.00165	0.00427	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Temozolomide—brain cancer	0.00162	0.0042	CcSEcCtD
Fluticasone Propionate—Pneumonia—Temozolomide—brain cancer	0.00161	0.00417	CcSEcCtD
Fluticasone Propionate—Erythema—Hydroxyurea—brain cancer	0.0016	0.00415	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Temozolomide—brain cancer	0.0016	0.00415	CcSEcCtD
Fluticasone Propionate—Infestation—Temozolomide—brain cancer	0.0016	0.00415	CcSEcCtD
Fluticasone Propionate—Nausea—Lomustine—brain cancer	0.00158	0.0041	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00154	0.00399	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—VAV1—brain cancer	0.00151	0.0128	CbGpPWpGaD
Fluticasone Propionate—Sinusitis—Temozolomide—brain cancer	0.0015	0.00389	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Etoposide—brain cancer	0.0015	0.00388	CcSEcCtD
Fluticasone Propionate—NR3C2—brain—brain cancer	0.00149	0.0121	CbGeAlD
Fluticasone Propionate—Ill-defined disorder—Hydroxyurea—brain cancer	0.00149	0.00385	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Carmustine—brain cancer	0.00148	0.00384	CcSEcCtD
Fluticasone Propionate—NR3C1—gonad—brain cancer	0.00148	0.012	CbGeAlD
Fluticasone Propionate—Connective tissue disorder—Carmustine—brain cancer	0.00146	0.00379	CcSEcCtD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—CDK4—brain cancer	0.00146	0.0124	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00145	0.0123	CbGpPWpGaD
Fluticasone Propionate—Malaise—Hydroxyurea—brain cancer	0.00144	0.00374	CcSEcCtD
Fluticasone Propionate—Pain—Procarbazine—brain cancer	0.00144	0.00374	CcSEcCtD
Fluticasone Propionate—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00144	0.0123	CbGpPWpGaD
Fluticasone Propionate—NR3C1—pituitary gland—brain cancer	0.00144	0.0117	CbGeAlD
Fluticasone Propionate—Hypoaesthesia—Temozolomide—brain cancer	0.00143	0.00371	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Temozolomide—brain cancer	0.00143	0.0037	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Etoposide—brain cancer	0.00141	0.00366	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Temozolomide—brain cancer	0.00141	0.00366	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Procarbazine—brain cancer	0.00139	0.00361	CcSEcCtD
Fluticasone Propionate—NR3C1—medulla oblongata—brain cancer	0.00139	0.0113	CbGeAlD
Fluticasone Propionate—Eye disorder—Carmustine—brain cancer	0.00139	0.0036	CcSEcCtD
Fluticasone Propionate—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00139	0.0118	CbGpPWpGaD
Fluticasone Propionate—PGR—brain—brain cancer	0.00138	0.0113	CbGeAlD
Fluticasone Propionate—Gastrointestinal pain—Procarbazine—brain cancer	0.00138	0.00358	CcSEcCtD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.00138	0.0117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—TRPC6—brain cancer	0.00137	0.0116	CbGpPWpGaD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00135	0.00351	CcSEcCtD
Fluticasone Propionate—Discomfort—Hydroxyurea—brain cancer	0.00135	0.00349	CcSEcCtD
Fluticasone Propionate—Eye disorder—Temozolomide—brain cancer	0.00134	0.00348	CcSEcCtD
Fluticasone Propionate—Urticaria—Procarbazine—brain cancer	0.00134	0.00348	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Procarbazine—brain cancer	0.00134	0.00346	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Procarbazine—brain cancer	0.00134	0.00346	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Temozolomide—brain cancer	0.00133	0.00346	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Carmustine—brain cancer	0.00133	0.00344	CcSEcCtD
Fluticasone Propionate—Oedema—Hydroxyurea—brain cancer	0.00131	0.00339	CcSEcCtD
Fluticasone Propionate—Mental disorder—Carmustine—brain cancer	0.0013	0.00338	CcSEcCtD
Fluticasone Propionate—Infection—Hydroxyurea—brain cancer	0.0013	0.00337	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Temozolomide—brain cancer	0.0013	0.00337	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Temozolomide—brain cancer	0.0013	0.00336	CcSEcCtD
Fluticasone Propionate—Erythema—Carmustine—brain cancer	0.00129	0.00336	CcSEcCtD
Fluticasone Propionate—Malnutrition—Carmustine—brain cancer	0.00129	0.00336	CcSEcCtD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00129	0.0109	CbGpPWpGaD
Fluticasone Propionate—Pneumonia—Etoposide—brain cancer	0.00129	0.00334	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Hydroxyurea—brain cancer	0.00128	0.00332	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Etoposide—brain cancer	0.00128	0.00332	CcSEcCtD
Fluticasone Propionate—Infestation—Etoposide—brain cancer	0.00128	0.00332	CcSEcCtD
Fluticasone Propionate—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00127	0.0108	CbGpPWpGaD
Fluticasone Propionate—NR3C1—midbrain—brain cancer	0.00127	0.0103	CbGeAlD
Fluticasone Propionate—Skin disorder—Hydroxyurea—brain cancer	0.00127	0.00329	CcSEcCtD
Fluticasone Propionate—Mental disorder—Temozolomide—brain cancer	0.00126	0.00326	CcSEcCtD
Fluticasone Propionate—Malnutrition—Temozolomide—brain cancer	0.00125	0.00324	CcSEcCtD
Fluticasone Propionate—Erythema—Temozolomide—brain cancer	0.00125	0.00324	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Procarbazine—brain cancer	0.00124	0.00323	CcSEcCtD
Fluticasone Propionate—NR3C1—spinal cord—brain cancer	0.00124	0.0101	CbGeAlD
Fluticasone Propionate—Vision blurred—Carmustine—brain cancer	0.00122	0.00316	CcSEcCtD
Fluticasone Propionate—Tremor—Carmustine—brain cancer	0.00121	0.00314	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.00121	0.0103	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.00121	0.0102	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Procarbazine—brain cancer	0.00119	0.0031	CcSEcCtD
Fluticasone Propionate—Agitation—Carmustine—brain cancer	0.00119	0.00308	CcSEcCtD
Fluticasone Propionate—Vision blurred—Temozolomide—brain cancer	0.00118	0.00306	CcSEcCtD
Fluticasone Propionate—Tremor—Temozolomide—brain cancer	0.00117	0.00304	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Hydroxyurea—brain cancer	0.00117	0.00302	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Temozolomide—brain cancer	0.00116	0.00301	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet homeostasis—TRPC6—brain cancer	0.00116	0.00981	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Procarbazine—brain cancer	0.00116	0.003	CcSEcCtD
Fluticasone Propionate—Agitation—Temozolomide—brain cancer	0.00115	0.00298	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Etoposide—brain cancer	0.00114	0.00297	CcSEcCtD
Fluticasone Propionate—Angioedema—Temozolomide—brain cancer	0.00114	0.00296	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—MPL—brain cancer	0.00113	0.00964	CbGpPWpGaD
Fluticasone Propionate—Malaise—Temozolomide—brain cancer	0.00113	0.00293	CcSEcCtD
Fluticasone Propionate—CYP3A5—endocrine gland—brain cancer	0.00113	0.00915	CbGeAlD
Fluticasone Propionate—Hypertension—Carmustine—brain cancer	0.00112	0.0029	CcSEcCtD
Fluticasone Propionate—Pain—Hydroxyurea—brain cancer	0.00112	0.0029	CcSEcCtD
Fluticasone Propionate—Dizziness—Procarbazine—brain cancer	0.00112	0.0029	CcSEcCtD
Fluticasone Propionate—NR3C1—endocrine gland—brain cancer	0.00112	0.00908	CbGeAlD
Fluticasone Propionate—Palpitations—Temozolomide—brain cancer	0.00111	0.00287	CcSEcCtD
Fluticasone Propionate—Chest pain—Carmustine—brain cancer	0.0011	0.00286	CcSEcCtD
Fluticasone Propionate—NR3C1—head—brain cancer	0.0011	0.00897	CbGeAlD
Fluticasone Propionate—Anxiety—Carmustine—brain cancer	0.0011	0.00285	CcSEcCtD
Fluticasone Propionate—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.00109	0.00929	CbGpPWpGaD
Fluticasone Propionate—Cough—Temozolomide—brain cancer	0.00109	0.00283	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—GFAP—brain cancer	0.00109	0.00924	CbGpPWpGaD
Fluticasone Propionate—Hypertension—Temozolomide—brain cancer	0.00108	0.0028	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Hydroxyurea—brain cancer	0.00108	0.00279	CcSEcCtD
Fluticasone Propionate—Eye disorder—Etoposide—brain cancer	0.00107	0.00279	CcSEcCtD
Fluticasone Propionate—Vomiting—Procarbazine—brain cancer	0.00107	0.00278	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Etoposide—brain cancer	0.00107	0.00277	CcSEcCtD
Fluticasone Propionate—Arthralgia—Temozolomide—brain cancer	0.00107	0.00276	CcSEcCtD
Fluticasone Propionate—Rash—Procarbazine—brain cancer	0.00106	0.00276	CcSEcCtD
Fluticasone Propionate—Dermatitis—Procarbazine—brain cancer	0.00106	0.00276	CcSEcCtD
Fluticasone Propionate—Anxiety—Temozolomide—brain cancer	0.00106	0.00275	CcSEcCtD
Fluticasone Propionate—Headache—Procarbazine—brain cancer	0.00106	0.00274	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00106	0.00274	CcSEcCtD
Fluticasone Propionate—Oedema—Carmustine—brain cancer	0.00106	0.00274	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—VAV1—brain cancer	0.00105	0.00895	CbGpPWpGaD
Fluticasone Propionate—Discomfort—Temozolomide—brain cancer	0.00105	0.00273	CcSEcCtD
Fluticasone Propionate—Infection—Carmustine—brain cancer	0.00105	0.00272	CcSEcCtD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00104	0.00887	CbGpPWpGaD
Fluticasone Propionate—Dry mouth—Temozolomide—brain cancer	0.00104	0.0027	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Etoposide—brain cancer	0.00104	0.00269	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Etoposide—brain cancer	0.00104	0.00269	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP2C9—brain cancer	0.00103	0.0935	CrCbGaD
Fluticasone Propionate—Body temperature increased—Hydroxyurea—brain cancer	0.00103	0.00268	CcSEcCtD
Fluticasone Propionate—Tachycardia—Carmustine—brain cancer	0.00103	0.00267	CcSEcCtD
Fluticasone Propionate—Oedema—Temozolomide—brain cancer	0.00102	0.00265	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Temozolomide—brain cancer	0.00102	0.00265	CcSEcCtD
Fluticasone Propionate—Infection—Temozolomide—brain cancer	0.00101	0.00263	CcSEcCtD
Fluticasone Propionate—NR3C1—central nervous system—brain cancer	0.00101	0.00818	CbGeAlD
Fluticasone Propionate—Nausea—Procarbazine—brain cancer	0.001	0.0026	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Temozolomide—brain cancer	0.001	0.0026	CcSEcCtD
Fluticasone Propionate—Skin disorder—Temozolomide—brain cancer	0.000992	0.00257	CcSEcCtD
Fluticasone Propionate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000991	0.00841	CbGpPWpGaD
Fluticasone Propionate—NR3C1—cerebellum—brain cancer	0.000983	0.008	CbGeAlD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000969	0.00823	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Hydroxyurea—brain cancer	0.000963	0.0025	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Carmustine—brain cancer	0.000963	0.0025	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Etoposide—brain cancer	0.000963	0.0025	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000954	0.00809	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000944	0.00801	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Carmustine—brain cancer	0.000942	0.00244	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00093	0.00241	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Etoposide—brain cancer	0.000929	0.00241	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000916	0.00778	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Temozolomide—brain cancer	0.00091	0.00236	CcSEcCtD
Fluticasone Propionate—Pain—Carmustine—brain cancer	0.000904	0.00234	CcSEcCtD
Fluticasone Propionate—Malaise—Etoposide—brain cancer	0.000903	0.00234	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Hydroxyurea—brain cancer	0.000894	0.00232	CcSEcCtD
Fluticasone Propionate—Cough—Etoposide—brain cancer	0.000874	0.00226	CcSEcCtD
Fluticasone Propionate—Pain—Temozolomide—brain cancer	0.000873	0.00226	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Carmustine—brain cancer	0.000871	0.00226	CcSEcCtD
Fluticasone Propionate—Hypertension—Etoposide—brain cancer	0.000864	0.00224	CcSEcCtD
Fluticasone Propionate—Dizziness—Hydroxyurea—brain cancer	0.000864	0.00224	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Carmustine—brain cancer	0.000864	0.00224	CcSEcCtD
Fluticasone Propionate—Chest pain—Etoposide—brain cancer	0.000852	0.00221	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000847	0.00219	CcSEcCtD
Fluticasone Propionate—CYP3A4—endocrine gland—brain cancer	0.000844	0.00687	CbGeAlD
Fluticasone Propionate—Discomfort—Etoposide—brain cancer	0.000842	0.00218	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Temozolomide—brain cancer	0.000842	0.00218	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Carmustine—brain cancer	0.000835	0.00217	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Carmustine—brain cancer	0.000835	0.00217	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Temozolomide—brain cancer	0.000835	0.00216	CcSEcCtD
Fluticasone Propionate—Vomiting—Hydroxyurea—brain cancer	0.000831	0.00215	CcSEcCtD
Fluticasone Propionate—Rash—Hydroxyurea—brain cancer	0.000824	0.00214	CcSEcCtD
Fluticasone Propionate—Dermatitis—Hydroxyurea—brain cancer	0.000823	0.00213	CcSEcCtD
Fluticasone Propionate—Headache—Hydroxyurea—brain cancer	0.000819	0.00212	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Etoposide—brain cancer	0.000817	0.00212	CcSEcCtD
Fluticasone Propionate—Infection—Etoposide—brain cancer	0.000812	0.0021	CcSEcCtD
Fluticasone Propionate—Urticaria—Temozolomide—brain cancer	0.000811	0.0021	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Temozolomide—brain cancer	0.000807	0.00209	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Temozolomide—brain cancer	0.000807	0.00209	CcSEcCtD
Fluticasone Propionate—NR3C1—brain—brain cancer	0.000799	0.0065	CbGeAlD
Fluticasone Propionate—Tachycardia—Etoposide—brain cancer	0.000798	0.00207	CcSEcCtD
Fluticasone Propionate—Skin disorder—Etoposide—brain cancer	0.000794	0.00206	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Carmustine—brain cancer	0.000779	0.00202	CcSEcCtD
Fluticasone Propionate—Nausea—Hydroxyurea—brain cancer	0.000776	0.00201	CcSEcCtD
Fluticasone Propionate—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000768	0.00652	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—central nervous system—brain cancer	0.000761	0.00619	CbGeAlD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000757	0.00643	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Temozolomide—brain cancer	0.000752	0.00195	CcSEcCtD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000745	0.00632	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Etoposide—brain cancer	0.000729	0.00189	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Carmustine—brain cancer	0.000723	0.00187	CcSEcCtD
Fluticasone Propionate—Pruritus—Temozolomide—brain cancer	0.000722	0.00187	CcSEcCtD
Fluticasone Propionate—Dizziness—Carmustine—brain cancer	0.000699	0.00181	CcSEcCtD
Fluticasone Propionate—Pain—Etoposide—brain cancer	0.000699	0.00181	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Temozolomide—brain cancer	0.000699	0.00181	CcSEcCtD
Fluticasone Propionate—Dizziness—Temozolomide—brain cancer	0.000675	0.00175	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Etoposide—brain cancer	0.000673	0.00175	CcSEcCtD
Fluticasone Propionate—Vomiting—Carmustine—brain cancer	0.000672	0.00174	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Etoposide—brain cancer	0.000668	0.00173	CcSEcCtD
Fluticasone Propionate—Rash—Carmustine—brain cancer	0.000666	0.00173	CcSEcCtD
Fluticasone Propionate—Dermatitis—Carmustine—brain cancer	0.000666	0.00173	CcSEcCtD
Fluticasone Propionate—Headache—Carmustine—brain cancer	0.000662	0.00172	CcSEcCtD
Fluticasone Propionate—Vomiting—Temozolomide—brain cancer	0.000649	0.00168	CcSEcCtD
Fluticasone Propionate—Urticaria—Etoposide—brain cancer	0.000649	0.00168	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—brain cancer	0.000646	0.00167	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—brain cancer	0.000646	0.00167	CcSEcCtD
Fluticasone Propionate—Rash—Temozolomide—brain cancer	0.000644	0.00167	CcSEcCtD
Fluticasone Propionate—Dermatitis—Temozolomide—brain cancer	0.000643	0.00167	CcSEcCtD
Fluticasone Propionate—Headache—Temozolomide—brain cancer	0.00064	0.00166	CcSEcCtD
Fluticasone Propionate—Nausea—Carmustine—brain cancer	0.000628	0.00163	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—VAV1—brain cancer	0.000622	0.00528	CbGpPWpGaD
Fluticasone Propionate—Nausea—Temozolomide—brain cancer	0.000607	0.00157	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—brain cancer	0.000602	0.00156	CcSEcCtD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000599	0.00509	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000591	0.00502	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—MYC—brain cancer	0.000588	0.00499	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000586	0.00497	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MPL—brain cancer	0.000585	0.00497	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Etoposide—brain cancer	0.000578	0.0015	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—STAT3—brain cancer	0.000567	0.00481	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—S100A10—brain cancer	0.000561	0.00476	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Etoposide—brain cancer	0.000559	0.00145	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000555	0.00471	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000555	0.00471	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000547	0.00465	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000541	0.00459	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Etoposide—brain cancer	0.00054	0.0014	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—brain cancer	0.000523	0.00444	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Etoposide—brain cancer	0.00052	0.00135	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—brain cancer	0.000515	0.00134	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—brain cancer	0.000515	0.00133	CcSEcCtD
Fluticasone Propionate—Headache—Etoposide—brain cancer	0.000512	0.00133	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—PDGFRA—brain cancer	0.000509	0.00432	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000509	0.00432	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000502	0.00427	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—RELA—brain cancer	0.000491	0.00417	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000486	0.00412	CbGpPWpGaD
Fluticasone Propionate—Nausea—Etoposide—brain cancer	0.000485	0.00126	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000472	0.00401	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000469	0.00398	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—ESR2—brain cancer	0.000468	0.00397	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—OR4C12—brain cancer	0.000464	0.00394	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—OR14C36—brain cancer	0.000464	0.00394	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000451	0.00383	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—IRS2—brain cancer	0.000447	0.00379	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—NOTCH2—brain cancer	0.000443	0.00376	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000434	0.00369	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000434	0.00368	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000423	0.00359	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000401	0.00341	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—BSG—brain cancer	0.000395	0.00335	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00039	0.00331	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000385	0.00327	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000377	0.0032	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PIK3CG—brain cancer	0.000377	0.0032	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000376	0.0032	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000373	0.00316	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—STAT3—brain cancer	0.000372	0.00316	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PIK3CG—brain cancer	0.000348	0.00296	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000346	0.00294	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000345	0.00292	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—EGFR—brain cancer	0.000338	0.00287	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—OR4C12—brain cancer	0.000336	0.00285	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—OR14C36—brain cancer	0.000336	0.00285	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00033	0.0028	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000309	0.00263	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—ERBB2—brain cancer	0.000307	0.0026	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000303	0.00257	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTCH2—brain cancer	0.000299	0.00254	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000299	0.00253	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000295	0.0025	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IRS2—brain cancer	0.000293	0.00249	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000292	0.00248	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000291	0.00247	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000288	0.00245	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—DTX2—brain cancer	0.000286	0.00242	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000285	0.00242	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—ESR2—brain cancer	0.000285	0.00242	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—OR4C12—brain cancer	0.000274	0.00233	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—OR14C36—brain cancer	0.000274	0.00233	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	0.00027	0.00229	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000269	0.00228	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000263	0.00223	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TRPC6—brain cancer	0.000259	0.0022	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000258	0.00219	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000254	0.00216	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—DNMT1—brain cancer	0.000251	0.00213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000239	0.00203	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—ABR—brain cancer	0.000235	0.00199	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000233	0.00198	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—DTX2—brain cancer	0.000233	0.00198	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—ESR2—brain cancer	0.000225	0.00191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—STAT3—brain cancer	0.000223	0.0019	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTCH2—brain cancer	0.000216	0.00184	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—NOTCH2—brain cancer	0.000213	0.00181	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—EGFR—brain cancer	0.000212	0.0018	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HES5—brain cancer	0.00021	0.00178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000209	0.00177	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000208	0.00176	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MYC—brain cancer	0.000208	0.00176	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STRADA—brain cancer	0.000203	0.00173	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VAV1—brain cancer	0.000194	0.00165	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000192	0.00163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP2C9—brain cancer	0.000188	0.0016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000184	0.00156	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000183	0.00155	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—SIRT1—brain cancer	0.000181	0.00154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTCH2—brain cancer	0.000177	0.0015	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—CTNNB1—brain cancer	0.000176	0.00149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HES5—brain cancer	0.000171	0.00145	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ABR—brain cancer	0.00017	0.00144	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000169	0.00143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000168	0.00143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STRADA—brain cancer	0.000166	0.00141	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	0.000165	0.0014	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GLI2—brain cancer	0.000164	0.00139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000161	0.00136	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—BSG—brain cancer	0.00016	0.00136	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000156	0.00132	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GLI1—brain cancer	0.000154	0.00131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—SHH—brain cancer	0.000154	0.00131	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—STAT3—brain cancer	0.000153	0.0013	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—DNMT1—brain cancer	0.000153	0.0013	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000152	0.00129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—TRPC6—brain cancer	0.000149	0.00126	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000148	0.00125	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MYC—brain cancer	0.000148	0.00125	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SUFU—brain cancer	0.000146	0.00124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTCH1—brain cancer	0.000146	0.00124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—SMO—brain cancer	0.000146	0.00124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000145	0.00123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000143	0.00121	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GFAP—brain cancer	0.000141	0.0012	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ABR—brain cancer	0.000139	0.00118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—IDH1—brain cancer	0.000138	0.00117	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ESR2—brain cancer	0.000137	0.00116	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GLI2—brain cancer	0.000134	0.00114	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HEY1—brain cancer	0.000134	0.00113	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000134	0.00113	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP2C9—brain cancer	0.000131	0.00111	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—DLL1—brain cancer	0.000131	0.00111	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH2—brain cancer	0.00013	0.0011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GLI1—brain cancer	0.000126	0.00107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CG—brain cancer	0.000123	0.00105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000121	0.00103	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SUFU—brain cancer	0.000119	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GFAP—brain cancer	0.000115	0.000978	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000112	0.000952	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—BSG—brain cancer	0.000112	0.000948	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SHH—brain cancer	0.000111	0.000946	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—VAV1—brain cancer	0.000111	0.000945	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SIRT1—brain cancer	0.00011	0.000938	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HEY1—brain cancer	0.000109	0.000927	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ENO2—brain cancer	0.000109	0.000925	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TRPC6—brain cancer	0.000107	0.000913	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—DLL1—brain cancer	0.000107	0.000909	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SMO—brain cancer	0.000106	0.000897	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTCH1—brain cancer	0.000106	0.000897	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—IDH1—brain cancer	9.6e-05	0.000815	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2C9—brain cancer	9.49e-05	0.000806	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SHH—brain cancer	9.11e-05	0.000773	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—brain cancer	8.99e-05	0.000763	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—DNMT1—brain cancer	8.83e-05	0.00075	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TRPC6—brain cancer	8.78e-05	0.000745	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL2—brain cancer	8.67e-05	0.000736	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SMO—brain cancer	8.63e-05	0.000733	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTCH1—brain cancer	8.63e-05	0.000733	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH2—brain cancer	8.45e-05	0.000717	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BSG—brain cancer	8.07e-05	0.000685	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VAV1—brain cancer	8.05e-05	0.000684	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR2—brain cancer	7.93e-05	0.000673	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ENO2—brain cancer	7.59e-05	0.000644	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH2—brain cancer	7.51e-05	0.000638	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—brain cancer	7.37e-05	0.000626	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—brain cancer	7.11e-05	0.000603	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CG—brain cancer	7.07e-05	0.0006	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—IDH1—brain cancer	6.94e-05	0.000589	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HES1—brain cancer	6.93e-05	0.000588	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH2—brain cancer	6.9e-05	0.000586	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDGFRA—brain cancer	6.6e-05	0.00056	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VAV1—brain cancer	6.58e-05	0.000559	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SPP1—brain cancer	6.4e-05	0.000544	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SIRT1—brain cancer	6.39e-05	0.000542	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS2—brain cancer	5.79e-05	0.000492	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HES1—brain cancer	5.66e-05	0.00048	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—brain cancer	5.57e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO2—brain cancer	5.49e-05	0.000466	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFRA—brain cancer	5.39e-05	0.000457	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SPP1—brain cancer	5.23e-05	0.000444	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—brain cancer	5.2e-05	0.000441	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—brain cancer	5.11e-05	0.000434	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—brain cancer	5.11e-05	0.000434	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—brain cancer	5e-05	0.000424	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—brain cancer	4.98e-05	0.000422	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS2—brain cancer	4.73e-05	0.000402	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2C9—brain cancer	4.41e-05	0.000375	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—brain cancer	4.33e-05	0.000367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—brain cancer	4.18e-05	0.000355	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—brain cancer	4.18e-05	0.000355	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RELA—brain cancer	4e-05	0.000339	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—brain cancer	3.97e-05	0.000337	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—brain cancer	3.81e-05	0.000323	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BSG—brain cancer	3.75e-05	0.000319	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—brain cancer	3.6e-05	0.000306	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—brain cancer	3.51e-05	0.000298	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—brain cancer	3.48e-05	0.000296	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—brain cancer	3.47e-05	0.000295	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RELA—brain cancer	3.26e-05	0.000277	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—brain cancer	3.24e-05	0.000275	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—IDH1—brain cancer	3.23e-05	0.000274	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—brain cancer	3.06e-05	0.00026	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—brain cancer	3.03e-05	0.000257	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—brain cancer	2.94e-05	0.00025	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—brain cancer	2.87e-05	0.000243	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—brain cancer	2.84e-05	0.000241	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—brain cancer	2.81e-05	0.000239	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—brain cancer	2.75e-05	0.000234	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO2—brain cancer	2.55e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—brain cancer	2.52e-05	0.000214	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—brain cancer	2.5e-05	0.000212	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—brain cancer	2.5e-05	0.000212	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—brain cancer	2.47e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—brain cancer	2.31e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—brain cancer	2.3e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—brain cancer	2.25e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—brain cancer	1.89e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—brain cancer	1.17e-05	9.93e-05	CbGpPWpGaD
